Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The complexities of hormonal influences and risk of Parkinson's disease.

Literature DB >> 24789470

The complexities of hormonal influences and risk of Parkinson's disease.

Connie Marras¹, Rachel Saunders-Pullman.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2014 PMID： 24789470 PMCID： PMC4347401 DOI： 10.1002/mds.25891

Source DB: PubMed Journal: Mov Disord ISSN： 0885-3185 Impact factor: 10.338

× No keyword cloud information.

32 in total

1. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.

Authors: R A Popat; S K Van Den Eeden; C M Tanner; V McGuire; A L Bernstein; D A Bloch; A Leimpeter; L M Nelson
Journal: Neurology Date: 2005-08-09 Impact factor: 9.910

2. Gender differences in Parkinson's disease.

Authors: K E Lyons; J P Hubble; A I Tröster; R Pahwa; W C Koller
Journal: Clin Neuropharmacol Date: 1998 Mar-Apr Impact factor: 1.592

3. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors: Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal: JAMA Date: 2007-04-04 Impact factor: 56.272

4. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions.

Authors: Shotaro Suzuki; Candice M Brown; Christopher D Dela Cruz; Enhua Yang; David A Bridwell; Phyllis M Wise
Journal: Proc Natl Acad Sci U S A Date: 2007-03-26 Impact factor: 11.205

5. Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen.

Authors: Alberto Ascherio; Marc G Weisskopf; Eilis J O'Reilly; Marjorie L McCullough; Eugenia E Calle; Carmen Rodriguez; Michael J Thun
Journal: Am J Epidemiol Date: 2004-11-15 Impact factor: 4.897

6. Increased risk of parkinsonism in women who underwent oophorectomy before menopause.

Authors: W A Rocca; J H Bower; D M Maraganore; J E Ahlskog; B R Grossardt; M de Andrade; L J Melton
Journal: Neurology Date: 2007-08-29 Impact factor: 9.910

7. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group.

Authors:
Journal: Ann Neurol Date: 1996-01 Impact factor: 10.422

8. Risk of Parkinson disease in women: effect of reproductive characteristics.

Authors: P Ragonese; M D'Amelio; G Salemi; P Aridon; M Gammino; A Epifanio; L Morgante; G Savettieri
Journal: Neurology Date: 2004-06-08 Impact factor: 9.910

9. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?

Authors: JoAnn E Manson; Shari S Bassuk
Journal: Am J Epidemiol Date: 2007-07-23 Impact factor: 4.897

10. Postmenopausal estrogen use affects risk for Parkinson disease.

Authors: Lillian J Currie; Madaline B Harrison; Joel M Trugman; James P Bennett; G Frederick Wooten
Journal: Arch Neurol Date: 2004-06

5 in total

1. Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.

Authors: Karen Marder; Yuanjia Wang; Roy N Alcalay; Helen Mejia-Santana; Ming-Xin Tang; Annie Lee; Deborah Raymond; Anat Mirelman; Rachel Saunders-Pullman; Lorraine Clark; Laurie Ozelius; Avi Orr-Urtreger; Nir Giladi; Susan Bressman
Journal: Neurology Date: 2015-06-10 Impact factor: 9.910

2. The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD.

Authors: Letizia Straniero; Rosanna Asselta; Salvatore Bonvegna; Valeria Rimoldi; Giada Melistaccio; Giulia Soldà; Massimo Aureli; Matteo Della Porta; Ugo Lucca; Alessio Di Fonzo; Anna Zecchinelli; Gianni Pezzoli; Roberto Cilia; Stefano Duga
Journal: Neurol Genet Date: 2020-10-20